Emami Paper Mills Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: May 15, 2025, 9:55 pm

Competitors of Emami Paper Mills Ltd

All Competitor Stocks of Emami Paper Mills Ltd

Quarterly Result

Last Updated: March 3, 2025, 4:37 pm

Below is a detailed analysis of the quarterly data for Emami Paper Mills Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

• For Sales, as of Dec 2024, the value is 454.31 Cr.. The value appears to be declining and may need further review. It has decreased from 495.09 Cr. (Sep 2024) to 454.31 Cr., marking a decrease of 40.78 Cr..
• For Expenses, as of Dec 2024, the value is 425.12 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 457.83 Cr. (Sep 2024) to 425.12 Cr., marking a decrease of 32.71 Cr..
• For Operating Profit, as of Dec 2024, the value is 29.19 Cr.. The value appears to be declining and may need further review. It has decreased from 37.26 Cr. (Sep 2024) to 29.19 Cr., marking a decrease of 8.07 Cr..
• For OPM %, as of Dec 2024, the value is 6.43%. The value appears to be declining and may need further review. It has decreased from 7.53% (Sep 2024) to 6.43%, marking a decrease of 1.10%.
• For Other Income, as of Dec 2024, the value is 1.49 Cr.. The value appears strong and on an upward trend. It has increased from 0.57 Cr. (Sep 2024) to 1.49 Cr., marking an increase of 0.92 Cr..
• For Interest, as of Dec 2024, the value is 15.72 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 14.79 Cr. (Sep 2024) to 15.72 Cr., marking an increase of 0.93 Cr..
• For Depreciation, as of Dec 2024, the value is 13.17 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 12.91 Cr. (Sep 2024) to 13.17 Cr., marking an increase of 0.26 Cr..
• For Profit before tax, as of Dec 2024, the value is 1.79 Cr.. The value appears to be declining and may need further review. It has decreased from 10.13 Cr. (Sep 2024) to 1.79 Cr., marking a decrease of 8.34 Cr..
• For Tax %, as of Dec 2024, the value is 5.03%. The value appears to be improving (decreasing) as expected. It has decreased from 25.07% (Sep 2024) to 5.03%, marking a decrease of 20.04%.
• For Net Profit, as of Dec 2024, the value is 1.70 Cr.. The value appears to be declining and may need further review. It has decreased from 7.59 Cr. (Sep 2024) to 1.70 Cr., marking a decrease of 5.89 Cr..
• For EPS in Rs, as of Dec 2024, the value is 0.28. The value appears to be declining and may need further review. It has decreased from 1.25 (Sep 2024) to 0.28, marking a decrease of 0.97.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 6:47 am

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: November 15, 2024, 12:35 am

Below is a detailed analysis of the balance sheet data for Emami Paper Mills Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2024, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 12.00 Cr..
• For Reserves, as of Sep 2024, the value is 796.00 Cr.. The value appears strong and on an upward trend. It has increased from 518.00 Cr. (Mar 2024) to 796.00 Cr., marking an increase of 278.00 Cr..
• For Borrowings, as of Sep 2024, the value is 640.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 850.00 Cr. (Mar 2024) to 640.00 Cr., marking a decrease of 210.00 Cr..
• For Other Liabilities, as of Sep 2024, the value is 423.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 334.00 Cr. (Mar 2024) to 423.00 Cr., marking an increase of 89.00 Cr..
• For Total Liabilities, as of Sep 2024, the value is 1,871.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,714.00 Cr. (Mar 2024) to 1,871.00 Cr., marking an increase of 157.00 Cr..
• For Fixed Assets, as of Sep 2024, the value is 1,076.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,085.00 Cr. (Mar 2024) to 1,076.00 Cr., marking a decrease of 9.00 Cr..
• For CWIP, as of Sep 2024, the value is 4.00 Cr.. The value appears to be declining and may need further review. It has decreased from 10.00 Cr. (Mar 2024) to 4.00 Cr., marking a decrease of 6.00 Cr..
• For Investments, as of Sep 2024, the value is 76.00 Cr.. The value appears strong and on an upward trend. It has increased from 45.00 Cr. (Mar 2024) to 76.00 Cr., marking an increase of 31.00 Cr..
• For Other Assets, as of Sep 2024, the value is 715.00 Cr.. The value appears strong and on an upward trend. It has increased from 574.00 Cr. (Mar 2024) to 715.00 Cr., marking an increase of 141.00 Cr..
• For Total Assets, as of Sep 2024, the value is 1,871.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,714.00 Cr. (Mar 2024) to 1,871.00 Cr., marking an increase of 157.00 Cr..

Notably, the Reserves (796.00 Cr.) exceed the Borrowings (640.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Emami Paper Mills Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 13.12. This value is within the healthy range. It has increased from 10.62 (Mar 23) to 13.12, marking an increase of 2.50.
• For Diluted EPS (Rs.), as of Mar 24, the value is 10.61. This value is within the healthy range. It has increased from 8.71 (Mar 23) to 10.61, marking an increase of 1.90.
• For Cash EPS (Rs.), as of Mar 24, the value is 23.90. This value is within the healthy range. It has increased from 22.60 (Mar 23) to 23.90, marking an increase of 1.30.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 87.70. It has increased from 75.24 (Mar 23) to 87.70, marking an increase of 12.46.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 87.70. It has increased from 75.24 (Mar 23) to 87.70, marking an increase of 12.46.
• For Dividend / Share (Rs.), as of Mar 24, the value is 1.60. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.60.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 329.56. It has decreased from 381.51 (Mar 23) to 329.56, marking a decrease of 51.95.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 39.61. This value is within the healthy range. It has increased from 37.04 (Mar 23) to 39.61, marking an increase of 2.57.
• For PBIT / Share (Rs.), as of Mar 24, the value is 29.65. This value is within the healthy range. It has increased from 25.87 (Mar 23) to 29.65, marking an increase of 3.78.
• For PBT / Share (Rs.), as of Mar 24, the value is 18.54. This value is within the healthy range. It has increased from 15.39 (Mar 23) to 18.54, marking an increase of 3.15.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 13.93. This value is within the healthy range. It has increased from 11.43 (Mar 23) to 13.93, marking an increase of 2.50.
• For PBDIT Margin (%), as of Mar 24, the value is 12.02. This value is within the healthy range. It has increased from 9.71 (Mar 23) to 12.02, marking an increase of 2.31.
• For PBIT Margin (%), as of Mar 24, the value is 8.99. This value is below the healthy minimum of 10. It has increased from 6.78 (Mar 23) to 8.99, marking an increase of 2.21.
• For PBT Margin (%), as of Mar 24, the value is 5.62. This value is below the healthy minimum of 10. It has increased from 4.03 (Mar 23) to 5.62, marking an increase of 1.59.
• For Net Profit Margin (%), as of Mar 24, the value is 4.22. This value is below the healthy minimum of 5. It has increased from 2.99 (Mar 23) to 4.22, marking an increase of 1.23.
• For Return on Networth / Equity (%), as of Mar 24, the value is 15.88. This value is within the healthy range. It has increased from 15.19 (Mar 23) to 15.88, marking an increase of 0.69.
• For Return on Capital Employeed (%), as of Mar 24, the value is 15.32. This value is within the healthy range. It has increased from 13.81 (Mar 23) to 15.32, marking an increase of 1.51.
• For Return On Assets (%), as of Mar 24, the value is 4.91. This value is below the healthy minimum of 5. It has increased from 3.50 (Mar 23) to 4.91, marking an increase of 1.41.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.43. This value is within the healthy range. It has decreased from 0.60 (Mar 23) to 0.43, marking a decrease of 0.17.
• For Total Debt / Equity (X), as of Mar 24, the value is 1.14. This value exceeds the healthy maximum of 1. It has decreased from 1.89 (Mar 23) to 1.14, marking a decrease of 0.75.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 1.08. It has decreased from 1.23 (Mar 23) to 1.08, marking a decrease of 0.15.
• For Current Ratio (X), as of Mar 24, the value is 1.04. This value is below the healthy minimum of 1.5. It has increased from 0.92 (Mar 23) to 1.04, marking an increase of 0.12.
• For Quick Ratio (X), as of Mar 24, the value is 0.58. This value is below the healthy minimum of 1. It has increased from 0.43 (Mar 23) to 0.58, marking an increase of 0.15.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 4.55. This value is within the healthy range. It has decreased from 5.85 (Mar 23) to 4.55, marking a decrease of 1.30.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 17.29. This value is below the healthy minimum of 20. It has decreased from 21.07 (Mar 23) to 17.29, marking a decrease of 3.78.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 10.08. This value is below the healthy minimum of 20. It has decreased from 10.66 (Mar 23) to 10.08, marking a decrease of 0.58.
• For Earning Retention Ratio (%), as of Mar 24, the value is 82.71. This value exceeds the healthy maximum of 70. It has increased from 78.93 (Mar 23) to 82.71, marking an increase of 3.78.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 89.92. This value exceeds the healthy maximum of 70. It has increased from 89.34 (Mar 23) to 89.92, marking an increase of 0.58.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 3.56. This value is within the healthy range. It has increased from 3.53 (Mar 23) to 3.56, marking an increase of 0.03.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 2.25. This value is below the healthy minimum of 3. It has increased from 2.09 (Mar 23) to 2.25, marking an increase of 0.16.
• For Enterprise Value (Cr.), as of Mar 24, the value is 1,535.11. It has decreased from 1,780.70 (Mar 23) to 1,535.11, marking a decrease of 245.59.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.76. This value is below the healthy minimum of 1. It has decreased from 0.77 (Mar 23) to 0.76, marking a decrease of 0.01.
• For EV / EBITDA (X), as of Mar 24, the value is 6.41. This value is within the healthy range. It has decreased from 7.95 (Mar 23) to 6.41, marking a decrease of 1.54.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.34. This value is below the healthy minimum of 1. It has increased from 0.29 (Mar 23) to 0.34, marking an increase of 0.05.
• For Retention Ratios (%), as of Mar 24, the value is 82.70. This value exceeds the healthy maximum of 70. It has increased from 78.92 (Mar 23) to 82.70, marking an increase of 3.78.
• For Price / BV (X), as of Mar 24, the value is 1.30. This value is within the healthy range. It has decreased from 1.49 (Mar 23) to 1.30, marking a decrease of 0.19.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.34. This value is below the healthy minimum of 1. It has increased from 0.29 (Mar 23) to 0.34, marking an increase of 0.05.
• For EarningsYield, as of Mar 24, the value is 0.12. This value is below the healthy minimum of 5. It has increased from 0.10 (Mar 23) to 0.12, marking an increase of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness